Appendical Perforation by Infection with Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli: Case Report


We report the very rare case of a huge appendical abscess with extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E. coli) as the pathogen. There have been several reports of appendical infections such as appendicitis and appendical abscess caused by ESBL-producing bacteria in adults. The treatment of ESBL-producing E. coli infection is specific, and ESBL-producing bacteria have recently been reported as pathogens associated appendicitis in children. To the best of our knowledge, this is the second report of perforated appendicitis with abscess due to ESBL-producing E. coli. We discuss the diagnostic modalities and treatments for appendical abscess with ESBL-producing E. coli. and propose that the patients with perforated appendicitis and abscess formation due to ESBL-producing E. coli should be administered the antibiotic MEPM within 2 weeks to treat the abscess more effec-tively without producing other multidrug-resistant bacteria.

Share and Cite:

H. Miyagi, T. Okada, S. Honda, M. Minato and A. Taketomi, "Appendical Perforation by Infection with Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli: Case Report," Surgical Science, Vol. 3 No. 1, 2012, pp. 53-55. doi: 10.4236/ss.2012.31009.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] S. Ito, H. Machida, T. Harada, et al., “Extended-Spectrum Beta-Lactamases-Producing Bacteria and Vesicoureteral Reflux in Children,” Pediatrics International, Vol. 52, No. 1, 2010, pp. 134-137. doi:10.1111/j.1442-200X.2009.03011.x
[2] D. L. Paterson and R. A. Bonomo, “Extended-Spectrum Beta-Lactamases: A Clinical Update,” Clinical Microbiology Reviews, Vol. 18, No. 4, 2005, pp. 657-686. doi:10.1128/CMR.18.4.657-686.2005
[3] P. L. Winokur, R. Canton, J. M. Casellas, et al., “Variations in the Prevalence of Strains Expressing an Extended-Spectrum Beta-Lactamase Phenotype and Characterization of isolates from Europe, the Americas, and the Western Pacific Region,” Clinical Infectious Diseases, Vol. 32, Suppl. 2, 2001, pp. 94-103. doi:10.1086/320182
[4] K. Yamaguchi and A. Ohno, “Investigation of the Susceptibility Trends in Japan to Fluoroquinolones and Other Antimicrobial Agents in a Nationwide Collection of Clinical Isolates: A Longitudinal Analysis from 1994 to 2002,” Diagnostic Microbiology and Infectious Disease, Vol. 52, No. 2, 2005, pp. 35-43. doi:10.1016/j.diagmicrobio.2005.02.009
[5] H. Knothe, P. Shah, V. Krcmery, et al., “Transferable Resistance to Cefotaxime, Cefoxitin, Cefamandole and Cefuroxime in Clinical Isolates of Klebsiella Pneumoniae and Serratia Marcescens,” Infection, Vol. 11, No. 6, 1983, pp. 315-317. doi:10.1007/BF01641355
[6] R. Hague, “What is the Threat from Extended Spectrum Beta-Lactamase-Producing Organisms in Children?” Archives of Disease in Childhood, Vol. 96, 2011, pp. 325-327. doi:10.1136/adc.2010.184911
[7] T. E. Peter, G. Deepakraj, J. Brian, et al., “Transmission of an Extended-Spectrum-Beta-Lactamase-Producing Es- cherichia coli (Sequence Type ST131) Strain between a Father and Daughter Resulting in Septic Shock and Emphysematous Pyelonephritis,” Journal of Clinical Microbiology, Vol. 47, No. 11, 2009, pp. 3780-3782. doi:10.1128/JCM.01361-09
[8] M. Nakata, Y. Miyauchi, M. Sonoda, et al., “A Case of Appendicitis with Postoperative Infections Due to ESBL- Producing E. coli,” Japanese Journal of Pediatric Surgery, Vol. 41, 2009, pp. 762-766.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.